| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 10/07/2010 | DE102007011449B4 Anordnung zum Testen der Zerfallszeit und der Wirkstofffreigabe von Prüflingen in Flüssigkeiten Arrangement for testing the disintegration time and the drug release of samples in liquids |
| 10/07/2010 | DE10122039B4 Verfahren und Vorrichtung zum Bestimmen des Brennwertes eines Gases Method and apparatus for determining the calorific value of a gas |
| 10/07/2010 | CA2757560A1 Multi-primer amplification method for barcoding of target nucleic acids |
| 10/07/2010 | CA2757518A1 Biomarkers for monitoring treatment of neuropsychiatric diseases |
| 10/07/2010 | CA2757406A1 Carcass cutting methods and apparatus |
| 10/07/2010 | CA2757333A1 Mouse models |
| 10/07/2010 | CA2757317A1 Anti bone-loss and anti attachment-loss effects of an oral composition |
| 10/07/2010 | CA2757245A1 Detection of infectious disease in a human or animal by measuring specific phagocytosis in a thin film sample of their anticoagulated blood |
| 10/07/2010 | CA2757210A1 C6orf167 peptides and vaccines containing the same |
| 10/07/2010 | CA2757175A1 Diagnosis of gluten-induced autoimmune diseases |
| 10/07/2010 | CA2757095A1 Bmp-alk3 antagonists and uses for promoting bone growth |
| 10/07/2010 | CA2756988A1 Anti-fcrh5 antibodies and immunoconjugates and methods of use |
| 10/07/2010 | CA2756919A1 Equine parasite detection |
| 10/07/2010 | CA2756156A1 Method for assaying prodefensin-a6 for the in vitro diagnosis of colorectal cancer |
| 10/07/2010 | CA2756109A1 Method for detecting substance in biological sample |
| 10/07/2010 | CA2756006A1 Method for detecting antibody against sith-1 in biological sample |
| 10/07/2010 | CA2755985A1 Genotoxicity testing |
| 10/07/2010 | CA2755486A1 Detection of fibrin and fibrinogen degradation products and associated methods of production and use for the detection and monitoring of cancer |
| 10/07/2010 | CA2755364A1 Biosensor with predetermined dose response curve and method of manufacturing |
| 10/07/2010 | CA2753718A1 Protein biomarkers for soft tissue disease diagnosis and as therapeutic targets for oral care intervention |
| 10/07/2010 | CA2753660A1 Metabolites for oral health and uses thereof |
| 10/07/2010 | CA2753358A1 Hplc separation and quantitation of heavy petroleum fractions |
| 10/06/2010 | EP2237276A1 Disc chucking method and disc driving apparatus |
| 10/06/2010 | EP2237220A2 Method of correcting image distortion |
| 10/06/2010 | EP2237047A1 Method and/or System for Measuring Concentration of Detection Target Using Transmission or Reflection of Light |
| 10/06/2010 | EP2237045A2 Method of obtaining image of disc and apparatus for driving disc |
| 10/06/2010 | EP2237042A1 Marker for determination of sensitivity to anti-cancer agent |
| 10/06/2010 | EP2237041A1 Detection of a therapeutic antibody in an experimental animal |
| 10/06/2010 | EP2237040A2 Determination of level of immunoglobulin fragmentation or modification and use of a trypsin inhibitor for preventing the same |
| 10/06/2010 | EP2237039A1 Encoded microparticles |
| 10/06/2010 | EP2237038A1 Medical articles coated with organopolysiloxane containing a protein solution and non-ionic surfactant |
| 10/06/2010 | EP2237037A1 Microfluidic device and use thereof |
| 10/06/2010 | EP2237036A1 Detection method and determination method for detection target |
| 10/06/2010 | EP2237035A2 Taxol derivatives for taxol immunoassay |
| 10/06/2010 | EP2237034A1 Device and method for recognising the correct usage of an alcohol measuring device |
| 10/06/2010 | EP2237033A1 Urine sample analyzer |
| 10/06/2010 | EP2237032A1 Method of evaluating biological equivalence |
| 10/06/2010 | EP2237031A2 Analyzer for nitric oxide in exhaled breath with multiple-use sensor |
| 10/06/2010 | EP2237030A1 Method for specifically detecting test substance using photocurrent, sensor unit used therefor, and measuring device |
| 10/06/2010 | EP2237027A1 Sensor device and a method of manufacturing the same |
| 10/06/2010 | EP2237024A2 Immunoassay Apparatus and Method of Determining Brightness Value of Target Area on Optical Image Using the Same |
| 10/06/2010 | EP2237019A2 Blood analyzer and method for determining existence and nonexistence of lymphoblasts in blood sample |
| 10/06/2010 | EP2237013A1 Rapid cell block embedding method and apparatus |
| 10/06/2010 | EP2236629A1 Nucleic acid probe-based diagnostic assays for prokaryotic and eukaryotic organisms |
| 10/06/2010 | EP2236626A1 Genomic imprinting for the prognosis of the course of colorectal adenocarcinoma |
| 10/06/2010 | EP2236625A1 Use of trefoil factor family 3 (tff3) in the prognosis of patients diagnosed with colorectal cancer |
| 10/06/2010 | EP2236620A2 Compositions and methods for detecting and treating HIV infection |
| 10/06/2010 | EP2236618A2 Compositions for assaying glycoprotein |
| 10/06/2010 | EP2236617A1 Methods of terminal sterilization of biofunctional compositions |
| 10/06/2010 | EP2236616A1 Peptide nucleic acid probes for analysis of microorganisms |
| 10/06/2010 | EP2236614A2 Brain endothelial cell expression patterns |
| 10/06/2010 | EP2236515A1 Component protein pa1698 for type-iii secretion system of pseudomonas aeruginosa |
| 10/06/2010 | EP2236512A1 Binding of pathological forms of proteins using conjugated polyelectrolytes |
| 10/06/2010 | EP2236200A1 Device for distributing particles in a fluid and methods therefor |
| 10/06/2010 | EP2236156A2 Methods for treating and diagnosing Psoriasis |
| 10/06/2010 | EP2235544A1 Methods, systems and computer program products for predicting responsiveness to a pharmaceutical therapy for obesity or evaluating investigational pharmaceutical agents |
| 10/06/2010 | EP2235543A1 Method to determine lipids |
| 10/06/2010 | EP2235542A1 Diagnostic in vitro method for assessing von willebrand disease and increased bleeding risk associated with von willebrand disease and acquired or congenital disorders of platelet function |
| 10/06/2010 | EP2235541A2 Methods of analyzing wound samples |
| 10/06/2010 | EP2235540A2 New method for diagnosing sjogren's syndrome |
| 10/06/2010 | EP2235539A2 Use of a protein or nitrated peptide sequence for implementing a diagnosis method |
| 10/06/2010 | EP2235538A1 Method for determining the sensitivity of patients suffering from a cancer disease to biological therapy |
| 10/06/2010 | EP2235537A2 Identification of predictive markers of response to dasatinib in human colon cancer |
| 10/06/2010 | EP2235536A1 Her-2 diagnostic methods |
| 10/06/2010 | EP2235535A2 Biomarkers for predicting the sensitivity of cells to immunomodulatory compounds during treatment of non-hodgkin's lymphoma |
| 10/06/2010 | EP2235534A1 Methods and products for identifying strains of bacteria |
| 10/06/2010 | EP2235533A2 Screening |
| 10/06/2010 | EP2235532A1 Assays for adsorbed influenza vaccines |
| 10/06/2010 | EP2235531A1 Assay for diagnosing streptococcus pneumoniae |
| 10/06/2010 | EP2235530A1 Determination and estimation of absorption and distribution of substances in brain tissue |
| 10/06/2010 | EP2235528A2 Use of activating transcription factor-2 (atf2) for detecting skin cancer |
| 10/06/2010 | EP2235527A2 Compositions and methods of detecting tiabs |
| 10/06/2010 | EP2235526A1 Porous particle reagent compositions, devices, and methods for biosensors |
| 10/06/2010 | EP2235525A1 Methods and kits for a color changing sample diluent. |
| 10/06/2010 | EP2235508A1 Method for controlling the register between a printed pattern and a three-dimensional pattern on a packaging material |
| 10/06/2010 | EP2235495A1 Method of analyzing a number of hydrocarbons contained in a drilling fluid, and associated device |
| 10/06/2010 | EP2235204A1 The accuracy of myeloperoxidase assays and the detection of myeloperoxidase autoantibodies |
| 10/06/2010 | EP2235200A2 Affinity tag nucleic acid and protein compositions, and processes for using same |
| 10/06/2010 | EP2235188A2 Transgenic non-human animals expressing human blood clotting factors |
| 10/06/2010 | EP2235057A2 G immunoglobulin used against anthrax toxins |
| 10/06/2010 | EP2235055A2 Ephrin type-a receptor 10 protein |
| 10/06/2010 | EP2234724A1 Apparatus and method for detecting dna damage |
| 10/06/2010 | EP2234687A1 Floating disk for separating blood components |
| 10/06/2010 | EP2156182B1 Detection of an analyte in a sample of hemolyzed whole blood |
| 10/06/2010 | EP2137539B1 Amiloride sensitive sodium channels associated with panic disorders |
| 10/06/2010 | EP2080024B1 Cross-spot |
| 10/06/2010 | EP1984735B1 Reagents and methods for cancer prognosis and pathological staging |
| 10/06/2010 | EP1904855B1 Csf diagnostic in vitro method for diagnosis of dementia and neuroinflammatory diseases |
| 10/06/2010 | EP1885744B1 Substrate for rpn 11 enzymatic activity |
| 10/06/2010 | EP1834263B1 Measuring system for the measurement of material concentrations in liquid media |
| 10/06/2010 | EP1745295B1 Methods, compositions and compound assays for inhibiting amyloid-beta protein production |
| 10/06/2010 | EP1706133B1 Methods of protecting against radiation using flagellin |
| 10/06/2010 | EP1694129B1 Method for determining the quality of a slaughtered animal carcass and quantities therein |
| 10/06/2010 | EP1658384B1 Method for early detection and monitoring of diseases by analysis of cell-surface-bound nucleic acids |
| 10/06/2010 | EP1551449B1 Reagents and methods for engaging unique clonotypic lymphocyte receptors |
| 10/06/2010 | EP1456650B1 Gfats as modifiers of the p53 pathway and methods of use |
| 10/06/2010 | EP1352077B1 Materials and methods relating to protein aggregation in neurodegenerative disease |
| 10/06/2010 | EP1254369B1 Cells for drug discovery |
| 10/06/2010 | EP1220906B1 Polynucleotides encoding members of the human b lymphocyte activation antigen b7 family and polypeptides encoded thereby |
| 10/06/2010 | EP0873363B1 High affinity human antibodies to tumor antigens |